Results 181 to 190 of about 12,413,959 (307)

Comparing Real-World Outcomes of Prophylaxis with Extended Half-life Factor IX (rIX-FP vs. rFIXFc and N9-GP) for Haemophilia B: An Analysis of Medical Chart Data from Germany. [PDF]

Adv Ther
Olivieri M, Yan S, Yang Y, Tomic R, Linhoff T, Zhang X, Drelich D, Jakobs N, Miesbach W.   +8 more
europepmc   +1 more source

Evaluation of coagulation disorders and iron deficiency in women with heavy menstrual bleeding

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 250-254, January 2026.
Abstract Objective To explore the incidence of congenital bleeding disorders (CBD), which may result in anemia, in a large cohort of women referred for heavy menstrual bleeding (HMB) in a specialized gynecologic unit. Methods Between January 2022 and January 2024, all women referred for HMB were screened.
Lucia Rugeri, Yelena Fruchou, Caroline Brodbeck, Marianne Bastien, Amandine Lioux, Giulia Gouy, Marion Cortet, Gil Dubernard, Yesim Dargaud   +8 more
wiley   +1 more source

Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional Study. [PDF]

Haemophilia
Wheeler AP, Abraham A, Barnes C, Brown Frandsen R, d'Oiron R, Eichler H, Hampton K, López-Jaime FJ, Lyu CJ, Tavares CMM, Nogami K, Sutton C, Windyga J, Zulfikar B, Castaman G.   +14 more
europepmc   +1 more source

Balancing Promise and Peril: Hemophilia Gene Therapy Insights

IUBMB Life, Volume 78, Issue 1, January 2026.
ABSTRACT Hemophilia is an inherited disorder characterized by impaired blood clotting caused by mutations in the genes responsible for producing coagulation factor (F) VIII (hemophilia A, HA) or FIX (hemophilia B, HB). Current treatment primarily relies on replacement therapy, involving frequent and costly infusions of FVIII or FIX concentrates.
Saicharan Akula, Ester Borroni, Alessia Cottonaro, Antonia Follenzi, Simone Merlin   +4 more
wiley   +1 more source

Remarkable Prolongation of Irreversible APTT and Non‐Significant Hemorrhage: A Rare High Titer of FVIII Inhibitor Case Report and Literature Review

Journal of Clinical Laboratory Analysis, Volume 40, Issue 2, January 2026.
Patient with a bladder cancer history presented was diagnosed with Acquired hemophilia A (AHA) according to imaging findings and laboratory tests. The parameters returned to normal after treatment of methylprednisolone and cyclophosphamide. With the recurrence of AHA, the patient was finally confirmed to have liver metastases.
Ke‐Han Zhang, Song‐Song Lu, Pei‐Liang Gao, Xue‐Ying Fu, Gui‐Ying Dong   +4 more
wiley   +1 more source

Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France. [PDF]

Ther Adv Hematol
Chambost H, Repessé Y, Genre-Volot F, Desprez D, Castet SM, Vanderbecken S, Zidi M, Gandossi C, Nüesch E, Palmborg H, Santagostino E, B-SURE Study Group .   +11 more
europepmc   +1 more source

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B. [PDF]

Glob Reg Health Technol Assess, 2020
Aiello A, Mancuso ME, Colombo A, Teruzzi C, Berto P.   +4 more
europepmc   +1 more source

Intra‐articular and intra‐osseous expanded adipose‐derived stromal cell injections for knee osteoarthritis‐related bone marrow lesions yield promising outcomes: Preliminary results in 16 athletes

Journal of Experimental Orthopaedics, Volume 13, Issue 1, January 2026.
Abstract Purpose To explore the results of a fluoroscopic‐guided intra‐osseous (IO) and intra‐articular (IA) injection of expanded adipose‐derived stromal cells (ASCs) in athletes with bone marrow lesions (BML) associated with knee osteoarthritis (OA).
Miguel A. Khoury, Emmanuel T. Papakostas, Theodorakys Marín Fermín, Montassar Tabben, Karim Chamari, Lorena Levi, Khaled Alkhelaifi, Pieter D'Hooghe   +7 more
wiley   +1 more source

Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross-Sectional Survey. [PDF]

Eur J Haematol
Clausen CML, Funding E, Tolver A, Jarden M.   +3 more
europepmc   +1 more source

Haemophilia B: database of point mutations and short additions and deletions--eighth edition [PDF]

, 1998
F. Giannelli
openalex   +1 more source